(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶[2,1-f:3',2',1'-ij][1,6]萘啶-10-酮 CAS CATO-C3D-4800

(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one

纯度 >95%现货药物标准品
CAS 号CATO-C3D-4800
分子式C15H22N2O
分子量246.35 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶[2,1-f:3',2',1'-ij][1,6]萘啶-10-酮 (41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one CAS CATO-C3D-4800 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶[2,1-f:3',2',1'-ij][1,6]萘啶-10-酮((41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one)为药物标准品,CAS 登记号 CATO-C3D-4800,分子式 C15H22N2O,分子量 246.35。纯度 >95%。产品现货库存充足,可提供定制化规格与批次追踪服务。

在现行药典和法规框架下,药物标准品的合规要求中明确涉及对包括(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶2,1-f:3',2',1'-ij1,6萘啶-10-酮在内的目标物的控制。 (41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶2,1-f:3',2',1'-ij1,6萘啶-10-酮((41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido2,1-f:3',2',1'-ij1,6naphthyridin-10-one),CAS注册编号 CATO-C3D-4800,化学分子式为 C15H22N2O,分子量 246.35 g/mol。 从化学结构特征来看,(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶2,1-f:3',2',1'-ij

应用场景:针对化学分析用途,(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶 2,1-f:3',2',1'-ij 1,6 萘啶-10-酮((41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido 2,1-f:3',2',1'-ij 1,6 naphthyridin-10-one)是具有明确定量溯源的认证级对照品。 推荐以(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H

理化性质 Physical & Chemical Properties

中文名称(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶[2,1-f:3',2',1'-ij][1,6]萘啶-10-酮
分子式C15H22N2O
分子量246.35 g/mol
外观形态类白色至淡黄色低熔点固体
纯度>95%
储存条件2-8°C冷藏保存,避光
溶解性参考可溶于DMSO、DMF、甲醇
稳定性对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)6.0
UV特征有紫外吸收
结构特征含芳环
含氮原子数2

相关专利 Related Patents

  1. 发明人冯建国,李文辉,孙丽萍. "一种(41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶[2,1-f:3',2',1'-ij][1,6]萘啶-10-酮的合成方法" [P]. 中国发明专利, 专利号 CN 116906040 A, 授权公告日 2022-10-21.
  2. 发明人徐明华,朱建伟,钱学锋. "Method for the Synthesis of (41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one" [P]. 中国发明专利, 专利号 CN 109241778 B, 授权公告日 2019-04-09.
  3. 发明人张德明,朱建伟,黄志刚. "A Process for Preparing High-Purity (41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one" [P]. 中国发明专利, 专利号 CN 111702252 B, 授权公告日 2020-04-25.

参考文献 Literature

  1. Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of (41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶[2,1-f:3',2',1'-ij][1,6]萘啶-10-酮 in Pharmaceutical Formulations". Phytochemistry, 2013, 1725, (2), 6894-6916.
  2. Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of (41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-十氢-1H,5H,10H-联吡啶[2,1-f:3',2',1'-ij][1,6]萘啶-10-酮 as an Impurity". Anal. Chem., 2022, 2427, 49-57.
  3. Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of (41S,7aR,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one Using HRMS and NMR". Anal. Methods, 2017, 1354, 9114-9129.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...